Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001193125-25-326989
Filing Date
2025-12-19
Accepted
2025-12-19 16:45:33
Documents
3

Document Format Files

Seq Description Document Type Size
1 F-1/A d31304df1a.htm F-1/A 514841
2 EX-23.1 d31304dex231.htm EX-23.1 1928
3 GRAPHIC g31304g70e73.jpg GRAPHIC 31973
  Complete submission text file 0001193125-25-326989.txt   562230
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW Australia 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW Australia 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: F-1/A | Act: 33 | File No.: 333-290598 | Film No.: 251588189
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)